. 2015 Jun 29;9:3361–3368. doi: 10.2147/DDDT.S86344

Table 3.

Dynamics of indicators of lipid-transport function in blood of patients with myocardial infarction undergoing treatment with atorvastatin during in-hospital period

Variable	Control (n=33)	Group 1: patients given atorvastatin 20 mg/day (n=110)		Group 2: patients given atorvastatin 40 mg/day (n=100)
Variable	Control (n=33)	Day 1	Day 12	Day 1	Day 12
TC (mmol/L)	4.5 (3.8; 4.6)	5.50 (4.3; 7.4)^a	4.90 (4.3; 6.0)^a,^c	5.8 (4.7; 7.4)^a	4.5 (3.9; 5.8)^b,^c
LDL (mmol/L)	2.26 (1.9; 2.3)	2.92 (2.2; 3.3)^a	2.76 (1.7; 3.6)	2.7 (2.0; 3.8)^a	2.5 (1.9; 3.2)^b,^c
HDL (mmol/L)	1.26 (1.1; 1.3)	0.88 (0.8; 1.1)^a	0.95 (0.77; 1.13)^a	0.9 (0.6; 1.2)^a	1.0 (0.9; 1.2)^a,^c
VLDL (mmol/L)	0.56 (0.4; 0.9)	1.10 (0.9; 1.4)^a	1.03 (0.71; 1.46)^a	11.2 (0.9; 1.3)^a	0.6 (0.5; 0.9)^c
apo-A1 (g/L)	1.54 (1.3; 1.65)	1.10 (0.9; 1.4)^a	1.23 (1.0; 1.6)^a,^c	1.1 (0.9; 1.2)^a	1.3 (1.15; 1.54)^a,^c
apo-B (g/L)	1.19 (1.0; 1.5)	1.75 (1.2; 1.9)^a	1.74 (1.07; 2.1)^a	1.7 (1.2; 1.9)^a	1.6 (1.1; 1.8)^b
TG (mmol/L)	1.50 (1.4; 1.7)	2.17 (1.5; 3.4)^a	2.10 (1.4; 2.8)^a	2.4 (1.9; 2.8)^a	2.0 (1.7; 2.4)^c
apo-B/apo-A1	0.81 (0.7; 1.0)	1.48 (0.9; 1.8)^a	1.24 (0.3; 1.8)^a	1.3 (1.0; 1.9)^a	1.0 (0.7; 1.5)^c
FFA (mmol/L)	0.35 (0.2; 0.4)	1.92 (1.0; 2.0)^a	0.53 (0.7; 1.2)^c	1.8 (1.1; 2.0)^a	0.8 (0.5; 1.0)^b,^c

Notes:

Significant difference from control (P<0.05).

Significant difference in indicator among groups on the 12th day.

Significant difference in indicator within the group on the first and 12th days.

Abbreviations: TC, total cholesterol; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; VLDL, very-low-density lipoprotein cholesterol; apo-A1, apolipoprotein A1; apo-B, apolipoprotein B; TG, triglyceride; FFA, free fatty acid.